R-Biopharm AG Revenue and Competitors

Darmstadt,

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • R-Biopharm AG's estimated annual revenue is currently $80.7M per year.(i)
  • R-Biopharm AG's estimated revenue per employee is $175,000

Employee Data

  • R-Biopharm AG has 461 Employees.(i)
  • R-Biopharm AG grew their employee count by 7% last year.

R-Biopharm AG's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
CFOReveal Email/Phone
3
VP, Sales & MarketingReveal Email/Phone
4
VP, Regulatory Affairs and Quality AssuranceReveal Email/Phone
5
Inventory Control ManagerReveal Email/Phone
6
Eastern Canada Regional ManagerReveal Email/Phone
7
Eastern and Central US Regional ManagerReveal Email/Phone
8
Midwestern US Territory ManagerReveal Email/Phone
9
Customer Service & Facilities ManagerReveal Email/Phone
10
Research & Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M90-36%$14.1MN/A
#2
$83.2M468-3%$251MN/A
#3
$14M1001%N/AN/A
#4
$14.6M0N/A$12.5MN/A
#5
$30.3M197-6%N/AN/A
#6
$0.1M6-25%$2.6MN/A
#7
$45.1M2932%N/AN/A
#8
$4.8M43-7%N/AN/A
#9
$399.3M203740%N/AN/A
#10
$44M2864%N/AN/A
Add Company

What Is R-Biopharm AG?

Imprint: r-biopharm.com/imprint R-Biopharm is a leading developer of test solutions for clinical diagnostics and food & feed analysis. In both sectors, the R-Biopharm test kits offer high precision and accuracy, key requirements where patient and consumer health is at risk. R-Biopharm AG was founded in 1988 as a subsidiary of Röhm GmbH in Darmstadt, Germany. In 1991 it was taken over by the present managing director, Dr. Ralf M. Dreher. Since 1996 R-Biopharm's quality management systems have been certified to the international standards ISO 9001 and in 2003 the company gained ISO 13485 quality management certification. From January 2000 R-Biopharm acquired sole worldwide distribution rights to Enzymatic BioAnalysis, a product developed by Roche (formerly BOEHRINGER Mannheim). In 2002 R-Biopharm took over Rhône Diagnostics Technologies in Scotland, another supplier of mycotoxin test kits, resulting in successful expansion of its position in the food and feed analysis sector. Today the German parent company R-Biopharm is represented by subsidiaries in the UK, USA, Italy, France, Latin America, Brasil, Spain, Australia, India and China as well as by a worldwide extensive network of more than 80 distributors. In addition, Switzerland, Austria and the Netherlands are represented by local Country Managers.

keywords:N/A

N/A

Total Funding

461

Number of Employees

$80.7M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

R-Biopharm AG News

2022-04-20 - Fecal Pancreatic Elastase Testing Market Is Set to Expand at ...

Immundiagnostik AG; Invivo Healthcare; DRG Instruments GMBH; Verisana Laboratories; BÜHLMANN Laboratories AG; CerTest Biotec S.L.; R-Biopharm AG...

2022-04-20 - Global In-Vitro Cancer Diagnostics Market Future Scope and ...

MDx Health Quest Diagnostics; R-Biopharm AG; Signature Diagnostics; Siemens Healthcare; Randox Laboratories; Epigenomics AG; Beckman Coulter...

2022-03-22 - Allergy Diagnostic Assay Kits Market Growth and Restrain ...

Siemens, Omega Diagnostics, R-Biopharm AG, Hycor Biomedical, Hob Biotech, Stallergenes Greer, Lincoln Diagnostics, Thermo Fisher Scientific,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$842.7M41510%N/A